Serial Biopsies Reveal Immune Activation During Treatment for Recurrent Glioblastoma
A recent multi-institutional study has demonstrated that repeated sampling of brain tumor tissue can reveal immune system activation in response to cancer treatment for patients with recurrent glioblastoma (GBM). The research, conducted by the Accelerating GBM Therapies Through Serial Biopsies TeamLab and led by investigators from the Mass General Brigham Cancer Institute, highlights the potential of serial biopsies to detect treatment responses that may not be visible through traditional imaging techniques.
UPDATES AND NEWS
Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells
More Than a Patient: How Holly Folgia Turned Her Cancer Journey Into Impact
One Surgery Could Prevent Most Ovarian Cancers, Surgeons Say | The ASCO Post
Conquering Cancer: Innovations Closing Gaps and Improving Outcomes | Milken Institute
BE PART OF THE MISSION
Stay Informed, Make an Impact
Subscribe
Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.
Give
Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.